Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.

[1]  J. Mckenney,et al.  National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. , 2015, Journal of clinical lipidology.

[2]  J. Mckenney,et al.  National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. , 2014, Journal of clinical lipidology.

[3]  K. Nemoto,et al.  Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults. , 2014, Journal of clinical lipidology.

[4]  A. Wierzbicki,et al.  Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.

[5]  T. Ninomiya,et al.  Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study. , 2014, Atherosclerosis.

[6]  S. Grundy.  An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia. , 2013, Journal of clinical lipidology.

[7]  Xiang Gao,et al.  Non-High-Density Lipoprotein Cholesterol on the Risks of Stroke: A Result from the Kailuan Study , 2013, PloS one.

[8]  P. Joshi,et al.  Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. , 2013, Journal of the American College of Cardiology.

[9]  Xiang Gao,et al.  Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study , 2013, Neurological research.

[10]  C. Ballantyne,et al.  Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. , 2012, Journal of clinical lipidology.

[11]  A. Zwinderman,et al.  Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. , 2012, JAMA.

[12]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[13]  Jing Chen,et al.  Mortality attributable to smoking in China. , 2009, The New England journal of medicine.

[14]  Y. Kokubo,et al.  Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. , 2009, Atherosclerosis.

[15]  M. Blaha,et al.  The importance of non-HDL cholesterol reporting in lipid management. , 2008, Journal of clinical lipidology.

[16]  M. Pencina,et al.  Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.

[17]  Christopher T Sempos,et al.  Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. , 2006, The American journal of cardiology.

[18]  Nader Rifai,et al.  Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men , 2005, Circulation.

[19]  S. Grundy,et al.  Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. , 2005, Diabetes care.

[20]  N. Cook,et al.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. , 2005, JAMA.

[21]  M. Elisaf,et al.  Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol , 2005, Journal of cardiovascular pharmacology and therapeutics.

[22]  Nader Rifai,et al.  Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. , 2004, Diabetes care.

[23]  P. Whelton,et al.  International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. , 2004, Ethnicity & disease.

[24]  P Langenberg,et al.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. , 2001, Archives of internal medicine.

[25]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[26]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[27]  P. Muntner,et al.  Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. , 2014, Journal of clinical lipidology.

[28]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[29]  K. Chien,et al.  patient-oriented and epidemiological research Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese , 2007 .

[30]  Wu Yangfen.  Current status of major cardiovascular risk factors in Chinese populations and their trends in the past two decades , 2001 .